SCHEMBL5773073

SCHEMBL5773073

FC(F)(F)c1ccc(-c2nocc2CCl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KIF11 P52732 4/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
STAT3 P40763 2/20 0.36
STAT1 P42224 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
GABRA5 P31644 3/20 0.36
CFTR P13569 1/20 0.36
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
DPP4 P27487 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774283 0.84 HIF1A (0.41) GSRMEN1KMT2AKIF11SIRT2
SCHEMBL21590874 0.79 CASP3 (0.38) GABRA5CASP3
SCHEMBL5772931 0.78 PTGS2 (0.42) GSRMEN1KMT2AMAPK13MAPK12
SCHEMBL3213310 0.78 PTGS2 (0.41) GSRMEN1KMT2AGABRA5LMNA
SCHEMBL5773336 0.77 FFAR4 (0.48)
SCHEMBL3659068 0.75 KIF11 (0.47) GSRMEN1KMT2AKIF11MKNK1
SCHEMBL28186259 0.71 MEN1 (0.39) GSRMEN1KMT2AKIF11MKNK1
SCHEMBL21590778 0.70 GABRA1 (0.43) MAPK14GABRA5
SCHEMBL31051598 0.70
SCHEMBL7504399 0.69 RXRA (0.32) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR GSR 1464/4885MEN1 2811/4885KMT2A 3907/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 GSR 1370/4885MEN1 2072/4885KMT2A 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.